Insider sells 17900 shares of $WVE

Chris Francis, identified as See Remarks of $WVE, recently conducted an insider sale, parting with 17,900 shares of the company on 02-26-2026 for an approximate value of $270,182. Information regarding this transaction was gleaned from a current SEC filing, revealing that this sale represented around 22.4% of their holdings in this specific class of stock. Post this divestment, they retained ownership of 61,867 shares of this $WVE stock class. Looking at the broader picture of insider trading activity within $WVE, insiders have engaged in market transactions a total of 45 times within the past half-year period. Among these interactions, 2 comprised acquisitions, while 43 constituted sales.

Diving deeper into the specifics of insider trades involving $WVE stock over the past 6 months, several noteworthy patterns emerged. For instance, PLC GSK executed a significant purchase of 1,470,000 shares, amounting to a considerable sum of $27,930,000. The See Remarks, Chris Francis, took part in 14 sales transactions but did not engage in any purchases, effectively selling off 485,483 shares for an estimated total of $7,102,264. Similarly, Kyle Moran, serving as the Chief Financial Officer, made no purchases but carried out 7 sales, liquidating 263,624 shares for an approximate value of $4,152,237. Other insiders like Aik Na Tan, Christian O Henry, Adrian Rawcliffe, Gregory L. Verdine, Mark Corrigan, and Heidi L Wagner were also actively involved in sales transactions during this period, varying in the number of shares sold and corresponding financial figures.

Moreover, notable movements were observed within the realm of hedge fund activities related to $WVE. A total of 143 institutional investors opted to augment their $WVE stock holdings, whereas 97 entities decided to reduce their positions in the most recent quarter. Instances of significant changes included FMR LLC adding 10,005,609 shares to their portfolio, DARWIN GLOBAL MANAGEMENT, LTD. including 7,298,421 shares, PRICE T ROWE ASSOCIATES INC /MD/ acquiring 3,362,880 shares, BELLEVUE GROUP AG shedding 2,603,940 shares, KYNAM CAPITAL MANAGEMENT, LP relinquishing 2,390,948 shares, BLACKROCK, INC. increasing their holdings by 2,218,094 shares, and PRIMECAP MANAGEMENT CO/CA/ expanding their position with an additional 2,196,632 shares.

Moving on to analyst ratings, industry experts have shared valuable insights on $WVE stock in recent reports. Out of these assessments, 9 firms have issued buy ratings, with no sell ratings in sight. Notable recommendations include the “Buy” rating from HC Wainwright & Co., the “Outperform” rating from Oppenheimer and Wedbush, the “Buy” rating from B. Riley Securities, and the “Outperform” rating from RBC Capital and Cantor Fitzgerald, among others.

In addition, several analysts have put forward price targets for $WVE, offering valuable guidance to investors. Over the past 6 months, a median target of $32.5 has been derived from a total of 12 analysts’ forecasts. Noteworthy price targets include those set by Benjamin Burnett from Wells Fargo at $27.0, Steve Seedhouse from Cantor Fitzgerald at $41.0, and Whitney Ijem from Canaccord Genuity at $43.0, providing investors with valuable reference points in assessing the future performance of $WVE.